In recent years, the concept of “cardiometabolic risk” is increasingly used in clinical practice. One of the most common diseases is non-alcoholic fatty liver disease (NAFLD) - a chronic liver disease that is considered as a component of some diseases associated with insulin resistance. The development of NAFLD on the background of comorbid pathology is closely associated with an increase in the degree of cardiometabolic risk, which can determine the prognosis and life expectancy of patients.The monograph presents the results of our own studies that demonstrated the involvement of “new” markers - C-reactive protein, tumor necrosis factor-α, endothelial dysfunction indicators such as: circulating desquamated endothelial cells, vascular endothelial growth factor and telomere length in the formation of cardiometabolic changes in patients with NAFLD on the background of subclinical hypothyroidism, which can lead to early vascular aging. The data obtained expands our understanding of cardiometabolic risk formation mechanisms, to predict the course of the disease and to individualize the strategy for the prevention of cardiovascular events in a comorbid patient.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
EUR 9,70 per la spedizione da Germania a Italia
Destinazione, tempi e costiDa: moluna, Greven, Germania
Condizione: New. Codice articolo 385946548
Quantità: Più di 20 disponibili
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In recent years, the concept of 'cardiometabolic risk' is increasingly used in clinical practice. One of the most common diseases is non-alcoholic fatty liver disease (NAFLD) - a chronic liver disease that is considered as a component of some diseases associated with insulin resistance. The development of NAFLD on the background of comorbid pathology is closely associated with an increase in the degree of cardiometabolic risk, which can determine the prognosis and life expectancy of patients.The monograph presents the results of our own studies that demonstrated the involvement of 'new' markers - C-reactive protein, tumor necrosis factor- , endothelial dysfunction indicators such as: circulating desquamated endothelial cells, vascular endothelial growth factor and telomere length in the formation of cardiometabolic changes in patients with NAFLD on the background of subclinical hypothyroidism, which can lead to early vascular aging. The data obtained expands our understanding of cardiometabolic risk formation mechanisms, to predict the course of the disease and to individualize the strategy for the prevention of cardiovascular events in a comorbid patient. 80 pp. Englisch. Codice articolo 9786202528726
Quantità: 2 disponibili
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
Taschenbuch. Condizione: Neu. Neuware -In recent years, the concept of ¿cardiometabolic risk¿ is increasingly used in clinical practice. One of the most common diseases is non-alcoholic fatty liver disease (NAFLD) - a chronic liver disease that is considered as a component of some diseases associated with insulin resistance. The development of NAFLD on the background of comorbid pathology is closely associated with an increase in the degree of cardiometabolic risk, which can determine the prognosis and life expectancy of patients.The monograph presents the results of our own studies that demonstrated the involvement of ¿new¿ markers - C-reactive protein, tumor necrosis factor-¿, endothelial dysfunction indicators such as: circulating desquamated endothelial cells, vascular endothelial growth factor and telomere length in the formation of cardiometabolic changes in patients with NAFLD on the background of subclinical hypothyroidism, which can lead to early vascular aging. The data obtained expands our understanding of cardiometabolic risk formation mechanisms, to predict the course of the disease and to individualize the strategy for the prevention of cardiovascular events in a comorbid patient.Books on Demand GmbH, Überseering 33, 22297 Hamburg 80 pp. Englisch. Codice articolo 9786202528726
Quantità: 2 disponibili
Da: AHA-BUCH GmbH, Einbeck, Germania
Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In recent years, the concept of 'cardiometabolic risk' is increasingly used in clinical practice. One of the most common diseases is non-alcoholic fatty liver disease (NAFLD) - a chronic liver disease that is considered as a component of some diseases associated with insulin resistance. The development of NAFLD on the background of comorbid pathology is closely associated with an increase in the degree of cardiometabolic risk, which can determine the prognosis and life expectancy of patients.The monograph presents the results of our own studies that demonstrated the involvement of 'new' markers - C-reactive protein, tumor necrosis factor- , endothelial dysfunction indicators such as: circulating desquamated endothelial cells, vascular endothelial growth factor and telomere length in the formation of cardiometabolic changes in patients with NAFLD on the background of subclinical hypothyroidism, which can lead to early vascular aging. The data obtained expands our understanding of cardiometabolic risk formation mechanisms, to predict the course of the disease and to individualize the strategy for the prevention of cardiovascular events in a comorbid patient. Codice articolo 9786202528726
Quantità: 1 disponibili